# World excl. Intra-EU Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore World excl. Intra-EU HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: World excl. Intra-EU (WXD)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $15.6M
- Products: 25
- Buyer markets: 28
- Average CAGR: +182.1%
- Global sector size: $426.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $284.2B | $12.9M | $108.9B | +1.6% | 21 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $30.3B | $200.2K | $21.2B | +5.6% | 12 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $24.6B | $412.8K | $9.1B | +43.8% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $372.5K | $8.0B | +20.7% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $224.3K | $5.0B | -2.3% | 3 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $4.4B | $80.7 | $4.9B | +2.6% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | $46.7K | $4.7B | -2.3% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $55.4K | $4.6B | -1.5% | 3 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $2.4B | $22.2K | $3.6B | +17.1% | 1 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $38.6 | $2.8B | -45.6% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $6.2B | $13.4K | $2.8B | -16.8% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $3.7B | $113.8 | $2.5B | +40.5% | 1 | +0.0% |
| HS 285390 - Phosphides, chemically defined or not, not ferrophosphorus: other inorganic compounds n.e.c. (including distilled, conductivity water and water of like purity): liquid air, rare gases removed or not: compressed air: amalgams, not precious metal amalgams | $1.3B | $38.0 | $2.4B | -46.8% | 1 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $3.0B | $82.7K | $2.0B | +16.7% | 1 | +0.0% |
| HS 310540 - Fertilizers, mineral or chemical: ammonium dihydrogenorthophosphate (monoammonium phosphate) and mixtures thereof with diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $1.2M | $1.8B | +2.1% | 1 | +0.2% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $56.1 | $1.4B | -17.6% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $102.3 | $1.4B | -13.5% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $875.7M | $712.8 | $1.3B | +19.9% | 1 | +0.0% |
| HS 310221 - Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | $965.4M | $67.0K | $1.3B | -64.3% | 1 | +0.1% |
| HS 290110 - Acyclic hydrocarbons: saturated | $613.2M | $41.7 | $1.1B | -50.9% | 1 | +0.0% |
| HS 293410 - Heterocyclic compounds: containing an unfused thiazole ring (whether or not hydrogenated) in the structure | $890.3M | $46.0K | $1.1B | +12129.3% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $2.2K | $1.0B | -15.2% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.5B | $210.7 | $1.0B | -21.2% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $9.1 | $981.1M | -43.7% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $842.4M | $31.4K | $965.2M | +10.7% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $33.7B calculated opportunity across 7 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- Netherlands (NLD): $20.6B calculated opportunity across 6 products.
- Canada (CAN): $10.1B calculated opportunity across 6 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- Germany (DEU): $9.7B calculated opportunity across 5 products.
- France (FRA): $9.0B calculated opportunity across 5 products.
- Belgium (BEL): $8.2B calculated opportunity across 2 products.
- United Kingdom (GBR): $8.1B calculated opportunity across 3 products.
- China (CHN): $7.1B calculated opportunity across 2 products.
- Mexico (MEX): $6.9B calculated opportunity across 3 products.
- Spain (ESP): $6.6B calculated opportunity across 2 products.

## Growth stars

- HS 293410: +12129.3% average CAGR, $1.1B calculated opportunity.
- HS 300215: +43.8% average CAGR, $9.1B calculated opportunity.
- HS 300212: +40.5% average CAGR, $2.5B calculated opportunity.
- HS 330499: +20.7% average CAGR, $8.0B calculated opportunity.
- HS 293399: +19.9% average CAGR, $1.3B calculated opportunity.
- HS 330210: +17.1% average CAGR, $3.6B calculated opportunity.
- HS 381800: +16.7% average CAGR, $2.0B calculated opportunity.
- HS 281820: +10.7% average CAGR, $965.2M calculated opportunity.
- HS 382499: +5.6% average CAGR, $21.2B calculated opportunity.
- HS 300214: +2.6% average CAGR, $4.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 21 buyer markets, $108.9B calculated opportunity.
- HS 382499: 12 buyer markets, $21.2B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 300215: 3 buyer markets, $9.1B calculated opportunity.
- HS 330300: 3 buyer markets, $5.0B calculated opportunity.
- HS 300439: 3 buyer markets, $4.7B calculated opportunity.
- HS 382200: 3 buyer markets, $4.6B calculated opportunity.
- HS 300214: 1 buyer markets, $4.9B calculated opportunity.
- HS 330210: 1 buyer markets, $3.6B calculated opportunity.
- HS 382600: 1 buyer markets, $2.8B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.